Refractory reverse amblyopia with atropine penalization

Area of Science:

• Ophthalmology
• Pediatric Medicine
• Vision Science

Background:

• Amblyopia, or 'lazy eye,' is a common cause of reduced vision in children.
• Pharmacological penalization using atropine eye drops is an effective treatment for amblyopia.
• Reverse amblyopia, where the untreated eye's vision worsens, is a known but less common complication.

Observation:

• A 4-year-old girl developed reverse amblyopia in her sound eye during atropine penalization therapy for amblyopia.
• This complication was resistant to standard treatment interventions.
• The condition persisted despite therapeutic efforts.

Findings:

• This case demonstrates that atropine penalization alone, without optical aids, can lead to refractory reverse amblyopia.
• The visual decline in the sound eye was significant and persistent.
• The patient's condition did not improve with conventional management strategies.

Implications:

• Highlights the critical need for vigilant monitoring of visual acuity in the sound eye during amblyopia treatment.
• Emphasizes the importance of regular ophthalmological follow-up for children receiving atropine penalization.
• Suggests a potential need for revised monitoring protocols or alternative treatment considerations in specific pediatric cases.